Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Jazz Pharmaceuticals PLC    JAZZ   IE00B4Q5ZN47

Delayed Quote. Delayed  - 05/03 07:58:45 pm
153.84 USD   +0.83%
04/26 JAZZ PHARMACEUT : to Report 2016 First Quarter Financial Results on ..
03/30 JAZZ PHARMACEUT : Announces FDA Approval of Defitelio® (defibrotide ..
03/30 JAZZ PHARMACEUT : Announces Webcast for Defitelio® (defibrotide sodi..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Jazz Pharmaceuticals PLC
Operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products.

The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded on January 18, 2012 and is headquartered in Dublin, Ireland.

Number of employees : 910 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceutical Products1,173100%1,325100% +12.95%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States1,00785.9%1,19390% +18.41%
Europe126.7210.8%103.617.8% -18.23%
All Other38.763.3%28.312.1% -26.97%
Managers
NameAgeSinceTitle
Bruce C. Cozadd, MBA522012Chairman & Chief Executive Officer
Russell J. Cox532012Chief Operating Officer & Executive Vice President
Matthew P. Young, MBA472013Chief Financial Officer & Executive Vice President
Mark G. Eller, PhD-2012Senior VP-Research & Clinical Development
Karen L. Smith MD, PhD482015Chief Medical Officer & Global Head-Research
Paul Treacy55-Senior Vice President-Technical Operations
Paul L. Berns492010Independent Director
Patrick G. Enright, MBA542012Independent Director
Seamus C. Mulligan552012Director
Ken W. O'Keefe, MBA492012Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 61,184,623 58,791,316 96.1% 0 0.0% 96.1%
Shareholders
NameEquities%
Putnam Investment Management LLC 10,363,098 16.9%
Fidelity Management & Research Co. 8,814,730 14.4%
The Vanguard Group, Inc. 4,114,013 6.72%
BlackRock Fund Advisors 2,970,706 4.86%
Westfield Capital Management Co. LP 2,487,288 4.07%
SSgA Funds Management, Inc. 1,238,089 2.02%
Janus Capital Management LLC 1,198,539 1.96%
Seamus C. Mulligan 1,102,579 1.80%
Herndon Capital Management LLC 984,219 1.61%
FIL Investment Advisors (UK) Ltd 965,744 1.58%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Specialty & Advanced Pharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
ABBVIE INC
BIOGEN INC
MERCK KGAA
KYOWA HAKKO KIRIN..
JAZZ PHARMACEUTIC..
MALLINCKRODT PLC
ZHANGZHOU PIENTZE..
YUHAN CORPORATION
COSMO PHARMACEUTI..
INDIVIOR PLC
THERAPEUTICSMD IN..
NICHI-IKO PHARMAC..
ADVANCED ACCELERA..
KISSEI PHARMACEUT..
-
DONG-A ST CO LTD
LG LIFE SCIENCES,..
REPLIGEN CORPORAT..
MAYNE PHARMA GROU..
SUPERNUS PHARMACE..
HUONS CO LTD
Sector Pharmaceuticals
Jazz Pharmaceuticals PLC : Connections
Vascular Cures
Longitude Capital Management Co. LLC
SutroVax, Inc.
Circ Pharma Ltd.
Nueva School
Raven Biotechnologies, Inc.
Stanford Health Care
Orbus Therapeutics, Inc.
InfaCare Pharmaceutical Corp.
Adapt Pharma Ltd.
Xanodyne Pharmaceuticals, Inc.
Beecken Petty O'Keefe & Co. LP
Company contact information
Jazz Pharmaceuticals Plc
Connaught House
One Burlington Road
4th Floor
Dublin 4

Phone : +353.1.634.7800
Fax : +353.1.634.7850
Web : www.jazzpharma.com
© 2016 People , Fundamentals and Ownership